Bipolar disorder gets misdiagnosed as depression more often than most people realize – and the consequences of that error can follow someone for years. The overlap in symptoms is real. Both conditions involve depressive episodes that look, feel, and respond to stress in nearly identical ways. When a person walks into an office describing exhaustion, low mood, loss of interest, and difficulty concentrating, there is nothing in that list that points clearly toward one diagnosis over the other.
I’ve spent years in integrated psychiatric care watching patients arrive who have been on antidepressants for months without meaningful improvement – sometimes with worsening mood instability – because a depressive episode was treated without anyone exploring whether mania or hypomania had ever been part of the picture. That distinction changes everything about treatment. An antidepressant given without a mood stabilizer to someone with bipolar disorder can trigger a manic episode. The biology of these two conditions is different, the medication protocols are different, and the long-term management is different.
This article explains how bipolar disorder and depression compare symptom by symptom, why misdiagnosis is so common, and what a thorough psychiatric evaluation actually looks for. If you or someone you care for has been in treatment for depression without clear results, this is worth reading carefully.
Bipolar Disorder vs Depression: How the Symptoms Compare
The confusion between bipolar disorder and depression is not a failure of clinical attention – it is a structural problem built into how these conditions present. During a depressive episode, a person with bipolar disorder and a person with major depressive disorder can look identical. The difference only becomes visible when you examine the full longitudinal history, including periods that may not have been identified as problematic at the time.
The table below shows where the two conditions overlap and where they diverge.
| Symptom / Feature | Major Depression | Bipolar Disorder |
|---|---|---|
| Depressive episodes | Present | Present (often the dominant phase) |
| Manic or hypomanic episodes | Absent | Required for diagnosis (full mania in Bipolar I; hypomania in Bipolar II) |
| Mood elevation, reduced need for sleep | Absent | Present during manic/hypomanic phases |
| Racing thoughts, increased talkativeness | Not characteristic | Common during elevated mood episodes |
| Impulsive decisions, risky behavior | Rarely | Common during manic episodes |
| Low mood, fatigue, hopelessness | Present | Present during depressive phase |
| Response to antidepressants alone | Often effective | May worsen cycling; mood stabilizer typically required |
| Age of first episode | Any age, often mid-adulthood | Often late teens to mid-twenties |
| Family history factor | Moderate genetic component | Strong genetic component |
The critical row is the second one. Major depression is defined by the absence of manic or hypomanic episodes. Bipolar disorder is defined by their presence – but a person may spend far more time in depression than in elevated mood states, particularly in Bipolar II. That asymmetry is exactly why the condition can go unrecognized for years.
Bipolar Disorder Symptoms in Adults: What Gets Overlooked
When adults with bipolar disorder describe their history, the depressive episodes are almost always what brought them into care. The elevated mood periods – the stretches of high energy, reduced sleep, and expansive thinking – often get reframed in memory as good patches, productive phases, or just feeling like themselves. Hypomania in particular rarely looks like illness to the person experiencing it. That is partly what makes it so easy to miss.
The depressive symptoms in bipolar disorder largely match what clinicians see in major depression. Ongoing sadness or emptiness, loss of interest in activities that used to matter, fatigue, difficulty concentrating, changes in sleep, and in more serious presentations, thoughts of death or self-harm. None of that points to bipolar disorder on its own.
The features that suggest bipolar disorder require more direct questioning – and sometimes, asking family members who have observed the person over time. Adults with bipolar disorder may report or have histories that include:
- Periods of significantly reduced sleep without feeling tired – sleeping three or four hours and feeling energized rather than exhausted
- Episodes of elevated or irritable mood that lasted days to weeks and felt distinctly different from baseline
- Markedly increased goal-directed activity – starting multiple projects, increased productivity, feeling driven in ways that later seemed out of character
- Rapid or pressured speech – talking faster than usual, difficulty being interrupted, thoughts moving faster than words
- Impulsive financial, sexual, or professional decisions that caused problems or required repair afterward
- Grandiosity or inflated self-confidence during elevated periods – a sense of special ability or importance that departed from the person’s usual self-assessment
- A family history of bipolar disorder, mania, or mood instability in first-degree relatives
The challenge is that someone presenting during a depressive episode may not spontaneously report any of this. Asking about depression is straightforward. Asking someone to recall and identify previous elevated mood episodes – and to recognize them as potentially pathological rather than just good periods – takes a different kind of clinical conversation.
Why Bipolar Disorder Gets Misdiagnosed as Depression
The misdiagnosis problem is well-documented. Research has consistently shown that a significant portion of people with bipolar disorder receive an initial diagnosis of depression, and many wait years before the correct diagnosis is established. The reasons are worth understanding, because they also explain what a better diagnostic process looks like.
First, people come in for help when they feel bad, not when they feel good. Someone in a hypomanic phase is unlikely to schedule a psychiatric appointment. They are sleeping less, accomplishing more, and feeling energized – the idea that something is wrong may not occur to them, or to the people around them. The clinical encounter happens during the depressive episode, and that is the data set the clinician has to work with.
Second, hypomania is genuinely difficult to identify. It is defined as a distinct period of elevated or irritable mood and increased energy that is observable to others and represents a clear change from baseline – but falls short of the severity or duration that characterizes full mania. It does not require hospitalization. It does not usually involve psychosis. Many people who experience it do not register it as a symptom at all.
Third, standard depression rating scales are not designed to capture bipolar features. A clinician relying primarily on tools like the PHQ-9 is measuring depressive symptom severity, not screening for mood episode history. Without a structured inquiry into prior elevated mood periods – using something like the Mood Disorder Questionnaire or a detailed clinical interview – the hypomanic history can go undetected entirely.
Fourth, in younger patients, the picture is further complicated by the overlap with ADHD, anxiety disorders, and the developmental turbulence of adolescence and early adulthood. Dr. Gonzalo Laje, who founded Washington Behavioral Medicine Associates and whose 2007 research published in the Archives of General Psychiatry examined bipolar diagnosis in youth, has worked directly with these diagnostic challenges. Early and accurate identification matters because the treatment path diverges significantly depending on which condition is present.
How Is Bipolar Disorder Diagnosed? What a Thorough Evaluation Involves
There is no blood test or brain scan that diagnoses bipolar disorder. The diagnosis is clinical – built from a careful, structured history that examines mood episode patterns across time, not just current symptoms.
A thorough evaluation for bipolar disorder typically includes:
- A thorough mood history – not just the current episode, but a longitudinal account of mood patterns, energy fluctuations, and behavioral changes over the person’s lifetime
- Structured screening tools designed specifically to surface hypomanic and manic features that may not emerge in general conversation
- Collateral information – input from a spouse, parent, or close family member who has observed the person over time and can describe mood periods the patient may not recall or may have normalized
- A thorough family history, since bipolar disorder has a strong genetic component and a family pattern of mood disorders, particularly mania or instability, raises clinical suspicion significantly
- Medical and neurological review to rule out thyroid dysfunction, substance use, medications, and other conditions that can produce mood instability
- Review of prior treatment responses – a history of antidepressants that triggered agitation, insomnia, or elevated mood, or that produced limited benefit across multiple trials, is clinically meaningful
The timeline matters as much as the symptom list. Two people can describe the same depressive symptoms and have fundamentally different diagnoses depending on what happened during the months or years between depressive episodes. That is why evaluation at WBMA is not limited to what is happening right now.
When Genetic Testing Adds Clarity to Bipolar Treatment
Getting the diagnosis right is the first hurdle. The second is finding a medication regimen that works – and in bipolar disorder, that process can take considerable time. Mood stabilizers like lithium, valproate, and lamotrigine each have different profiles of effectiveness, tolerability, and side effects. Not every medication works equally well for every person, and the trial-and-error process of finding the right combination can be frustrating and sometimes destabilizing.
Pharmacogenomic testing – genetic testing that examines how a person’s genes affect medication metabolism and response – represents a meaningful shift in how that process can unfold. Rather than working through medication options based purely on clinical profile and prior response history, genetic data can inform which medications are more or less likely to be effective or poorly tolerated for a specific individual.
Dr. Laje’s research has contributed directly to this area. His 2021 work examined the use of genetic markers to predict lithium response in patients with bipolar disorder. Framed practically, his research helps identify which medications may work for bipolar disorder before treatment begins – reducing the number of ineffective trials and the time patients spend without adequate mood stabilization.
This is not a guarantee. Genetic testing in psychiatry is a clinical tool that informs decision-making, not a definitive predictor of outcomes. The genetic testing and psychiatry page explains in more detail how this information gets applied at WBMA. What it can do is narrow the range of options and give the prescribing clinician more data to work with from the start – which for someone who has already gone through years of misdiagnosis, is worth a great deal.
What Psychiatric Care for Bipolar Disorder Looks Like at WBMA
Washington Behavioral Medicine Associates serves patients in the Chevy Chase, Bethesda, and greater Washington, D.C. area who are dealing with mood disorders ranging from first-episode depression to complex bipolar presentations that have not responded well to prior treatment.
For patients where bipolar disorder is a diagnostic question, the evaluation process goes beyond symptom checklists. It includes the kind of careful longitudinal history described above, a review of prior medication responses, collateral input where appropriate, and, in cases where pharmacogenomic information would be useful, genetic testing to guide medication selection.
Our psychiatry services cover the full diagnostic and treatment process – from initial evaluation through ongoing psychiatric medication management as a care plan develops over time. For patients who have already been diagnosed but are not finding adequate stability with current medications, that medication management process is where genetic data often becomes most useful.
If you have been treated for depression without clear benefit, or if mood instability has been part of your history in ways that did not feel like illness at the time, that history is worth exploring with a clinician who takes the full picture into account. Contact WBMA to schedule a psychiatric evaluation and start with an honest assessment of what has and has not worked.
Frequently Asked Questions
Can bipolar disorder be mistaken for depression?
Yes – and it happens frequently. Because people with bipolar disorder spend a significant portion of their time in depressive episodes, and because hypomanic or manic phases are often not recognized as symptoms by the person experiencing them, the condition often gets diagnosed initially as major depressive disorder. Studies suggest that many people with bipolar disorder wait several years before receiving an accurate diagnosis. The key difference is the presence of elevated or irritable mood episodes that go beyond the person’s typical baseline – but identifying those episodes requires asking directly and examining a person’s full mood history rather than just their current presentation.
What tests diagnose bipolar disorder?
Bipolar disorder is diagnosed through a clinical evaluation, not a laboratory test or imaging study. A thorough assessment includes a structured mood history covering the person’s full lifetime, screening tools designed to identify hypomanic and manic features, collateral information from people who have observed the patient over time, a family history review, and a medical workup to rule out other causes of mood instability. Pharmacogenomic testing does not diagnose bipolar disorder, but it can inform medication selection once the diagnosis has been established by helping predict which mood stabilizers may be most effective or best tolerated for a specific individual.
What is the difference between Bipolar I and Bipolar II?
Bipolar I disorder involves at least one manic episode – a distinct period of elevated or expansive mood and increased energy lasting at least seven days, severe enough to cause significant impairment and sometimes requiring hospitalization. Bipolar II disorder involves hypomanic episodes rather than full mania. Hypomania is a less severe elevation in mood and energy that is observable to others and represents a clear change from baseline, but does not cause the level of functional impairment associated with full mania. Both types include depressive episodes, and both require different treatment approaches than major depressive disorder alone.
Why do antidepressants sometimes make bipolar disorder worse?
Antidepressants can, in some people with bipolar disorder, trigger a switch into mania or hypomania, increase the frequency of mood episodes, or contribute to a pattern called rapid cycling – four or more mood episodes per year. This is one of the clinical reasons that accurate diagnosis matters before treatment begins. Standard antidepressants are generally not recommended as stand-alone treatment for bipolar depression. When antidepressants are used at all, current guidelines typically indicate pairing them with a mood stabilizer. This is also why a history of poor or destabilizing responses to antidepressants is a clinically meaningful part of any mood disorder evaluation.
How long does it take to get a bipolar disorder diagnosis?
Research consistently shows that the path from first symptoms to accurate diagnosis takes years for many people with bipolar disorder – often due to the reasons outlined above, including the tendency to come in for care during depression rather than elevated mood episodes, and the challenge of identifying hypomania retrospectively. A thorough initial evaluation at a practice equipped to take a detailed mood history, gather collateral information, and use structured diagnostic tools can significantly shorten that process. The goal is not to rush to a label, but to gather enough longitudinal information that the clinical picture becomes clear rather than forcing a diagnosis on incomplete data.
